Release MSS5
Free
1.0.0for iPhone, iPod touch
Age Rating
Release MSS5 Screenshots
About Release MSS5
Release MSS5 Clinical Study App. contains content that is new and is tailored for the phase 3 study of Nabiximols Oromucosal Spray entitled:
A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients with Multiple Sclerosis. The clinical study app. enables study participants to complete daily eDiary entries and view scheduled study appointments during study participation.
GWSP20105 – Study Participant App. The App does not provide medical advice. Please consult with your study doctor with any questions or concerns you may have regarding your individual needs or medical conditions or any related questions about your involvement in the study.
A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients with Multiple Sclerosis. The clinical study app. enables study participants to complete daily eDiary entries and view scheduled study appointments during study participation.
GWSP20105 – Study Participant App. The App does not provide medical advice. Please consult with your study doctor with any questions or concerns you may have regarding your individual needs or medical conditions or any related questions about your involvement in the study.
Show More
What's New in the Latest Version 1.0.0
Last updated on Jun 3, 2021
Version History
1.0.0
Jun 3, 2021
Release MSS5 FAQ
Click here to learn how to download Release MSS5 in restricted country or region.
Check the following list to see the minimum requirements of Release MSS5.
iPhone
Requires iOS 10.0 or later.
iPod touch
Requires iOS 10.0 or later.
Release MSS5 supports English, Czech, Polish, Romanian, Spanish